Julio Ballestas
Psychiatry · Hollywood, FLNPI 1841521069
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 167 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 33.2% of the total. Reporting peaked in 2023 at $1,479 and has fallen 85.8% since, to $210 in 2024.
Across 167 payments — averaging $19.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Alkermes, Inc.$385
- Teva Pharmaceuticals USA, Inc.$322
- Johnson & Johnson$281
- Takeda Pharmaceuticals U.S.A., Inc.$189
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$172
- plus $811 from 16 others
What the payments were for
- Food & beverage$3,13397%
- Education$1063%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 62 | $1,076 |
| Alkermes, Inc. | 19 | $385 |
| Teva Pharmaceuticals USA, Inc. | 13 | $322 |
| Johnson & Johnson | 15 | $281 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $189 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $172 |
| Lundbeck LLC | 6 | $148 |
| Almatica Pharma LLC | 6 | $130 |
| Otsuka America Pharmaceutical, Inc. | 5 | $113 |
| Merck | 3 | $53 |
| Ironshore Pharmaceuticals Inc. | 3 | $51 |
| Sunovion Pharmaceuticals Inc. | 2 | $42 |
| Idorsia Pharmaceuticals US Inc | 2 | $39 |
| Bausch Health US, LLC | 2 | $39 |
| Alfasigma USA, Inc. | 2 | $38 |
| Neurocrine Biosciences, Inc. | 1 | $31 |
| Tempus AI, Inc | 1 | $28 |
| Livanova USA, Inc. | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Avanir Pharmaceuticals, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $14 |
How this compares
$3,238 in reported general payments places this provider in the 80th percentile of 2,059 psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $140 |
| Buspirone Hcl | 11 | $45 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Hollywood
- Andrew CutlerLakewood Ranch$5.7M
- Richard JacksonBoca Raton$3.6M
- Ilan MelnickCoral Gables$2.8M
- Todd BroderSt Augustine$1.6M
- Heather LuingSaint Augustine$1.5M
- Todd GatesWest Melbourne$1.2M
- Lawrence ReccoppaGainesville$968K
- Thomas ValenteLeesburg$967K
- Michelle ScargleClearwater$926K
- David SheehanTampa$631K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.